Tomomi Okamoto

Red Abbey Venture Partners LLC (Red Abbey Venture Partners) is a venture capital firm subsidiary of Red Abbey LLC founded in 2004 by Philip Goelet, W. Matthew Zuga, and Frank Adair Bonsal. The firm is headquartered in Baltimore, Maryland.

The Israel Japan Chamber of Commerce was founded in 1956 and is based in Tel Aviv, Israel. The Israeli company has been operating for many years to develop commercial ties and create a platform for business between Israel and Japan. The non-profit company's description emphasizes its efforts to foster a friendship society between the two countries, inviting people to enjoy, learn, and become a part of a Japanese experience.

Nippon Steel Corp. engages in the production and development of steel materials. Its products include steel, flat-rolled plates, pipes, tubes, pig iron, and other titanium and aluminum products. Its operations are carried out through the following segments: Steelmaking and Steel Fabrication, Engineering and Construction, Urban Development, Chemicals, New Materials, and System Solutions. The Steelmaking and Steel Fabrication segment include pig iron, secondary steel products, specialty steel, pipe and tubes, steel sections and flat-rolled products. The Engineering and Construction comprise of iron and steelmaking plants, industrial machinery and equipment, industrial furnaces, energy facilities and plants, chemical plants, and other various energy-related solutions. The Urban Development segment involves real estate and condominium development. The Chemicals segment entail pitch coke, pitch, naphthalene, phthalic anhydride, carbon black, liquid crystal display, and other various chemical products. The New Material segments consist of rolled metallic foils, semiconductor bonding wire and microballs, carbon-fiber composite products, polysilicon for solar cells, fine ceramic products metal catalyst carriers for cleaning automotive emissions. The System Solutions segment contains computer systems engineering and consulting services. The company was founded on March 31, 1970 and is headquartered in Tokyo, Japan.

SBI Trans-Science Inc (SBI Trans-Science) is a venture capital subsidiary of SBI Investment Co Ltd founded in 2001. The firm is headquartered in Tokyo, Japan.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.